Welcome to our dedicated page for Blackrock SEC filings (Ticker: BLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BlackRock, Inc. filings document the regulatory record of an asset manager with NYSE-listed common stock and 3.750% notes due 2035. Form 8-K disclosures furnish earnings releases and Regulation FD materials, report results of operations, and record material agreements such as amendments to the company's revolving credit facility.
Proxy and governance filings cover board elections, director independence, executive compensation, pay-versus-performance data and shareholder voting matters. Other 8-K disclosures describe compensation arrangements linked to BlackRock's private markets investment funds, capital-structure information for registered securities, and governance actions affecting the board and senior executive incentive programs.
Protara Therapeutics reports that BlackRock, Inc. beneficially owns 3,387,459 shares of Common Stock, representing 6.3% of the class as of 03/31/2026. The filing states BlackRock has sole voting power for 3,347,945 shares and sole dispositive power for 3,387,459 shares. The schedule notes various persons may have rights to dividends or sale proceeds and is signed by a BlackRock Managing Director on 04/27/2026.
Protara Therapeutics reports that BlackRock, Inc. beneficially owns 3,387,459 shares of Common Stock, representing 6.3% of the class as of 03/31/2026. The filing states BlackRock has sole voting power for 3,347,945 shares and sole dispositive power for 3,387,459 shares. The schedule notes various persons may have rights to dividends or sale proceeds and is signed by a BlackRock Managing Director on 04/27/2026.
Nutex Health Inc. Schedule 13G filing shows BlackRock, Inc. reported beneficial ownership of 367,633 shares of Common Stock, representing 5.3% of the class as of 03/31/2026. The filing states BlackRock has sole voting power over 361,034 shares and sole dispositive power over 367,633 shares. The cover notes that these holdings reflect certain Reporting Business Units of BlackRock and do not include securities held by other BlackRock business units. The document is signed by a BlackRock Managing Director on 04/27/2026.
Nutex Health Inc. Schedule 13G filing shows BlackRock, Inc. reported beneficial ownership of 367,633 shares of Common Stock, representing 5.3% of the class as of 03/31/2026. The filing states BlackRock has sole voting power over 361,034 shares and sole dispositive power over 367,633 shares. The cover notes that these holdings reflect certain Reporting Business Units of BlackRock and do not include securities held by other BlackRock business units. The document is signed by a BlackRock Managing Director on 04/27/2026.
BlackRock, Inc. files Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 324,758 shares of First United Corp Common Stock. The filing states this equals 4.99% of the class, with 319,470 shares of sole voting power and 324,758 shares of sole dispositive power. The signature is dated 04/27/2026.
BlackRock, Inc. amended a Schedule 13G to report beneficial ownership of 567,222 shares of JAKKS PACIFIC INC common stock, representing 4.95% of the class. The filing lists 559,044 shares with sole voting power and states the amendment was signed on 04/27/2026.
BlackRock, Inc. amended a Schedule 13G to report beneficial ownership of 567,222 shares of JAKKS PACIFIC INC common stock, representing 4.95% of the class. The filing lists 559,044 shares with sole voting power and states the amendment was signed on 04/27/2026.
BlackRock, Inc. files Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 324,758 shares of First United Corp Common Stock. The filing states this equals 4.99% of the class, with 319,470 shares of sole voting power and 324,758 shares of sole dispositive power. The signature is dated 04/27/2026.
Sable Offshore Corp reports a Schedule 13G disclosure showing BlackRock, Inc. beneficially owns 9,126,401 shares of Class A Stock, representing 6.2% of the class. The filing lists sole voting power of 8,939,542 shares and sole dispositive power of 9,126,401 shares as reported by BlackRock's Reporting Business Units.
The Schedule 13G names BlackRock, Inc. (50 Hudson Yards, New York) as filer and is signed by Spencer Fleming, Managing Director, dated 04/27/2026.
Sable Offshore Corp reports a Schedule 13G disclosure showing BlackRock, Inc. beneficially owns 9,126,401 shares of Class A Stock, representing 6.2% of the class. The filing lists sole voting power of 8,939,542 shares and sole dispositive power of 9,126,401 shares as reported by BlackRock's Reporting Business Units.
The Schedule 13G names BlackRock, Inc. (50 Hudson Yards, New York) as filer and is signed by Spencer Fleming, Managing Director, dated 04/27/2026.
BlackRock, Inc. amended its Schedule 13G to report beneficial ownership of 4,946,412 shares of ARS Pharmaceuticals, Inc. common stock (CUSIP 82835W108), representing 4.98% of the class. The filing lists 4,860,113 shares as sole voting power and 4,946,412 shares as sole dispositive power. The amendment is signed by Spencer Fleming, Managing Director, dated 04/27/2026.
BlackRock, Inc. amended its Schedule 13G to report beneficial ownership of 4,946,412 shares of ARS Pharmaceuticals, Inc. common stock (CUSIP 82835W108), representing 4.98% of the class. The filing lists 4,860,113 shares as sole voting power and 4,946,412 shares as sole dispositive power. The amendment is signed by Spencer Fleming, Managing Director, dated 04/27/2026.
BlackRock, Inc. filed an Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,685,605 shares of Compass Diversified Holdings common stock, equal to 4.9% of the class. The filing shows sole voting power for 3,619,153 shares and sole dispositive power for 3,685,605 shares. The filing is signed by Spencer Fleming on 04/27/2026.
BlackRock, Inc. filed an Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,685,605 shares of Compass Diversified Holdings common stock, equal to 4.9% of the class. The filing shows sole voting power for 3,619,153 shares and sole dispositive power for 3,685,605 shares. The filing is signed by Spencer Fleming on 04/27/2026.
BlackRock, Inc. reported beneficial ownership of 394,174 shares of Bankwell Financial Group, Inc. common stock, representing 4.9% of the class as of 03/31/2026. The filing lists 386,698 shares as sole voting power and 394,174 as sole dispositive power. The Schedule 13G/A amendment is signed by a Managing Director on 04/27/2026.
BlackRock, Inc. reported beneficial ownership of 394,174 shares of Bankwell Financial Group, Inc. common stock, representing 4.9% of the class as of 03/31/2026. The filing lists 386,698 shares as sole voting power and 394,174 as sole dispositive power. The Schedule 13G/A amendment is signed by a Managing Director on 04/27/2026.
KKR & Co. Inc. ownership disclosure: BlackRock, Inc. filed an amendment to a Schedule 13G reporting beneficial ownership of 44,343,828 shares of Class A common stock, representing 4.96% of the class as shown on the cover page dated 03/31/2026. The filing lists sole voting power of 40,319,699 shares and sole dispositive power of 44,343,828 shares. The amendment is signed by Spencer Fleming, Managing Director, on 04/27/2026.
KKR & Co. Inc. ownership disclosure: BlackRock, Inc. filed an amendment to a Schedule 13G reporting beneficial ownership of 44,343,828 shares of Class A common stock, representing 4.96% of the class as shown on the cover page dated 03/31/2026. The filing lists sole voting power of 40,319,699 shares and sole dispositive power of 44,343,828 shares. The amendment is signed by Spencer Fleming, Managing Director, on 04/27/2026.
European Wax Center Inc amendment to Schedule 13G/A reports 2,193,916 shares of Class A Stock beneficially owned by BlackRock, Inc., representing 4.98% of the class. The filing states BlackRock has sole voting power over 2,163,779 shares and sole dispositive power over 2,193,916 shares. The cover lists the issuer address and CUSIP 29882P106. The filing is signed by Spencer Fleming as Managing Director on 04/27/2026 and includes Exhibit 24 and Exhibit 99.
European Wax Center Inc amendment to Schedule 13G/A reports 2,193,916 shares of Class A Stock beneficially owned by BlackRock, Inc., representing 4.98% of the class. The filing states BlackRock has sole voting power over 2,163,779 shares and sole dispositive power over 2,193,916 shares. The cover lists the issuer address and CUSIP 29882P106. The filing is signed by Spencer Fleming as Managing Director on 04/27/2026 and includes Exhibit 24 and Exhibit 99.